Enzo-logo-750-500.jpg
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
October 29, 2024 19:59 ET | Enzo Biochem, Inc.
FARMINGDALE, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal fourth quarter ended July 31, 2024 and...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
June 13, 2024 16:20 ET | Enzo Biochem, Inc.
FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2024. ...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
March 13, 2024 16:26 ET | Enzo Biochem, Inc.
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. ...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
February 01, 2024 08:30 ET | Enzo Biochem, Inc.
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting...
Enzo-logo-750-500.jpg
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
December 15, 2023 16:20 ET | Enzo Biochem, Inc.
FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023. ...
Enzo-logo-750-500.jpg
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
November 06, 2023 08:00 ET | Enzo Biochem, Inc.
FARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fourth quarter ended July 31, 2023, and the...
Enzo-logo-750-500.jpg
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
October 30, 2023 16:15 ET | Enzo Biochem, Inc.
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed...
Enzo-logo-750-500.jpg
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
September 06, 2023 08:30 ET | Enzo Biochem, Inc.
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of...
Enzo-logo-750-500.jpg
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
July 24, 2023 16:27 ET | Enzo Biochem, Inc.
Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
June 14, 2023 19:21 ET | Enzo Biochem, Inc.
- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering...